~~<i id='5474058A4D'><strike id='5474058A4D'><tt id='5474058A4D'><pre id='5474058A4D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

Wikipedia

author：leisure time 2025-09-06 04:38:30 - browse：5

An FDA sign — health policy coverage from STAT — Sarah Silbiger/Getty Images

WASHINGTON — There’s about to be a new acronym in town.

The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning.

That overhaul includes a new name: Meet the Office of Inspections and Investigations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Covid vaccines: Private market messier than government rollout

knowledge

focus

explore

leisure time

focus

AdobeNewdatareleasedThursdaybytheNationalScienceFoundationshowtheexodusofyounglifescientistsfromtheI

WSS

After a drawn out lobbying fight, ARPA

What Congress can do to address the rural doctor shortage

Data show record exodus of life scientists from academia

Data show record exodus of life scientists from academia

Menendez indictment could see pharma lose a key ally

EpiPen alternative approval delay highlights citizen petition issue

hotspot

Wikipedia

knowledge

What does generative AI mean for health care? We asked experts

Biogen shutters digital health group, ends Apple study, in cost cutting move

As demand for Covid shots wanes, Moderna seeks its next success

Address the ethical violations that led to 'Three Identical Strangers'

Continuity nursing helped my family in our darkest PICU moments

Hearing on Medicare drug price negotiation gets unusually heated

Supreme Court strikes down use of affirmative action

How AI helped researchers track recovery from depression

How to save PrEP access — and even expand it

Inequities make cancer less preventable for women: report

focus

Covid vaccines: Private market messier than government rollout

Inequities make cancer less preventable for women: report

Ionis has late

How the Dana

Hearing on Medicare drug price negotiation gets unusually heated

Biogen shutters digital health group, ends Apple study, in cost cutting move

explore

leisure time

focus

focus